We are live on ! Find out more
LAB icon

Standard BioTools
LAB

141 hedge funds and large institutions have $543M invested in Standard BioTools in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

13% more capital invested

Capital invested by funds: $480M → $543M (+$62.5M)

2.53% more ownership

Funds ownership: 73.23% → 75.76% (+2.5%)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2% less funds holding

Funds holding: 144 → 141 (-3)

11% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 45

21% less call options, than puts

Call options by funds: $72K | Put options by funds: $91K

Holders
141
Holders Change
-3
Holders Change %
-2.08%
% of All Funds
2.02%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
21
Increased
40
Reduced
45
Closed
22
Calls
$72K
Puts
$91K
Net Calls
-$19K
Net Calls Change
-$1.17M

Top Buyers

1
CC
Casdin Capital
New York
+$14.3M
2
HBWM
Hollow Brook Wealth Management
New York
+$10.8M
3
Morgan Stanley
Morgan Stanley
New York
+$4.53M
4
Northern Trust
Northern Trust
Illinois
+$3.19M
5
Charles Schwab
Charles Schwab
California
+$3.13M

Top Sellers

1
AIM
ARK Investment Management
Florida
-$7.3M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2.14M
3
NAMA
Nikko Asset Management Americas
New York
-$2.09M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$2.08M
5
ICM
Invenomic Capital Management
Massachusetts
-$1.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nisa Investment Advisors
101
Nisa Investment Advisors
Missouri
$35K +$28.9K +14,732 +434%
TPC
102
Takeda Pharmaceutical Company
Japan
$31.9K – – –
Two Sigma Advisers
103
Two Sigma Advisers
New York
$26.7K -$48.2K -24,600 -64%
Wolverine Trading
104
Wolverine Trading
Illinois
$26.5K +$27K +13,808 New
Amundi
105
Amundi
France
$26.1K – – –
Focus Partners Wealth
106
Focus Partners Wealth
Massachusetts
$25.1K +$25.5K +13,002 New
Corient Private Wealth
107
Corient Private Wealth
Florida
$25.1K +$5.88K +3,000 +30%
SAM
108
Shell Asset Management
Netherlands
$25K +$25K +12,763 New
EWA
109
Evolution Wealth Advisors
Florida
$23.6K – – –
Simplex Trading
110
Simplex Trading
Illinois
$22K +$15.4K +7,889 +196%
FCH
111
Freestone Capital Holdings
Washington
$22K – – –
Pictet Asset Management
112
Pictet Asset Management
Switzerland
$21.9K – – –
PP
113
Paloma Partners
Connecticut
$21.6K +$21.9K +11,183 New
Envestnet Asset Management
114
Envestnet Asset Management
Illinois
$20.4K +$1.07K +546 +5%
AB
115
Amalgamated Bank
New York
$20K – – –
Wealth Enhancement Advisory Services
116
Wealth Enhancement Advisory Services
Minnesota
$19.7K +$20K +10,197 New
Mariner
117
Mariner
Kansas
$19.6K -$3.8K -1,941 -16%
Fidelity Investments
118
Fidelity Investments
Massachusetts
$16K +$8.57K +4,377 +112%
CM
119
Caption Management
Oklahoma
$15.4K – – –
CTB
120
Country Trust Bank
Illinois
$14.6K +$14.8K +7,552 New
TRCT
121
Tower Research Capital (TRC)
New York
$7.66K +$7.77K +3,970 New
Comerica Bank
122
Comerica Bank
Texas
$4.66K +$382 +195 +9%
SAM
123
Silverback Asset Management
North Carolina
$2.51K -$58.7K -29,958 -96%
SSB
124
Sandy Spring Bank
Maryland
$1.93K – – –
AF
125
Allworth Financial
California
$1.84K +$210 +107 +13%
3 4
5
6 7

LAB Hedge Fund Activity: Q3 2024 in Review

141 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2024, worth a combined $543M — up 13% from $480M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LAB and 21 opened new positions — a net loss of 1 holder — while 45 trimmed existing stakes and 40 added.

The largest buyer was Casdin Capital, adding an estimated $14.3M. The largest seller was ARK Investment Management, cutting an estimated $7.3M.

  • 141 institutional investors held Standard BioTools (LAB) as of Q3 2024, down from 144 in Q2 2024.
  • Funds reported $543M of Standard BioTools stock for Q3 2024, up 13% quarter-over-quarter.
  • 21 funds opened new Standard BioTools positions in Q3 2024 and 22 closed out, a net change of -1 holder.
  • The largest Standard BioTools buyer in Q3 2024 was Casdin Capital, an estimated $14.3M added.
  • The largest Standard BioTools seller in Q3 2024 was ARK Investment Management, an estimated $7.3M sold.

Based on aggregated 13F filings for Q3 2024.